300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Social Impact
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Burkina Faso
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Canada
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
United Kingdom
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Spain
Albania
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Angola
Europe
Grenada
Israel
Iceland
Cyprus
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Qatar
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in Ireland (August 2026)

The most active venture capital funds investing in Ireland Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Ireland Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Enterprise Ireland
VC Fund
35 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Health Care $494k–$12M
SOSV
VC Fund
19 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Western Development Commission
VC Fund
14 Ireland, United States Seed, Venture - Series Unknown Health Care, Medical Device, Biotechnology $702k–$17M
Kernel Capital
VC Fund
8 Ireland, United Kingdom, France Seed, Series A Software, Information Technology, Health Care $531k–$9M
Irrus Investments
VC Fund
8 Ireland, Sweden, United States Seed, Venture - Series Unknown Health Care, Medical Device, Biotechnology $713k–$24M
Atlantic Bridge
VC Fund
7 United States, Ireland, United Kingdom Series A, Series B Software, Information Technology, Artificial Intelligence $4.5M–$62M
Fountain Healthcare Partners
VC Fund
6 Ireland, United States, France Series A, Series B, Series C Health Care, Biotechnology, Medical $3.3M–$110M
Seroba Life Sciences
VC Fund
6 Ireland, United States, United Kingdom Series A, Series B Health Care, Biotechnology, Medical $4.6M–$105M
Faber
VC Fund
5 Portugal, United States, United Kingdom Seed, Pre-Seed, Series A Artificial Intelligence, Software, SaaS $29k–$25M
European Investment Bank
VC Fund
5 France, Germany, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy $16M–$726M
Elkstone Capital Partners
VC Fund
5 Ireland, United Kingdom, United States Seed, Series A Software, Artificial Intelligence, Health Care $797k–$18M
AIB Seed Capital Fund
VC Fund
5 Ireland, United States, Jersey Seed, Series A Software, Health Care, Medical $549k–$8.1M
Boole Investment Syndicate
VC Fund
4 Ireland, Estonia, United States Seed, Series A Biotechnology, SaaS, Software $623k–$2.2M
HBAN
VC Fund
4 Ireland, United Kingdom, United States Seed, Series A Software, Health Care, Medical Device $623k–$9.2M
HBAN Medtech Syndicate
VC Fund
4 Ireland Seed, Series B Medical Device, Medical, Health Care $1.3M–$11M
Atlantic Bridge University Fund
VC Fund
4 Ireland, United States Seed, Series A, Series B Health Care, Medical Device, Big Data $823k–$80M
SciFounders
VC Fund
3 United States, Ireland, United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Medical $400k–$21M
Furthr VC
VC Fund
3 Ireland Seed, Venture - Series Unknown Software, Medical Device, Medical $753k–$17M
Act Venture Capital
VC Fund
3 Ireland, United States, United Kingdom Seed, Series A Software, Information Technology, Artificial Intelligence $823k–$13M
The Yield Lab Europe
VC Fund
3 Ireland, France, United Kingdom Seed, Series A, Venture - Series Unknown AgTech, Agriculture, Biotechnology $1M–$10M
Lightstone Ventures
VC Fund
2 United States, Ireland, India Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7M–$105M
Enterprise Equity
VC Fund
2 Ireland, United States, United Kingdom Seed, Series B Software, Information Technology, Health Care $549k–$7.5M
Pareto Holdings
VC Fund
2 United States, France, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, FinTech $125k–$35M
Artis Ventures
VC Fund
2 United States, United Kingdom, India Series A, Series B, Seed Health Care, Biotechnology, Software $2M–$127M
Infinity Capital
VC Fund
2 United States, Ireland, Canada Series B, Series D Semiconductor, E-Commerce, Electronics
SVG Ventures
VC Fund
2 United States, Canada, Ireland Pre-Seed, Seed AgTech, Agriculture, Farming
HealthCap
VC Fund
2 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $5.7M–$92M
Lynett Capital
VC Fund
2 United States, Kenya, Nigeria Seed, Series A, Pre-Seed FinTech, Software, SaaS $120k–$49M
Ascentifi
VC Fund
2 Ireland Seed, Series A, Venture - Series Unknown Health Care, Medical Device, Medical $2.3M–$34M
ARCH Venture Partners
VC Fund
2 United States, China, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $10M–$250M
Gaingels
VC Fund
2 United States, Canada, Mexico Seed, Series A, Series B Software, Health Care, Artificial Intelligence $1M–$100M
DeepIE Ventures Management Co.
VC Fund
2 Ireland, France, Switzerland Seed, Series A Manufacturing, AgTech, Software $648k–$5.5M
LSP Dementia Fund
VC Fund
2 Belgium, Ireland, United States Series A, Series B, Post-IPO Equity Biotechnology, Health Care, Life Science $39M–$39M
Ascent Capital
VC Fund
1 India, United States, Ireland Series C, Series B Financial Services, Banking, Health Care $2.5M–$50M
Cedas Foundation
VC Fund
1 Ireland, United States Seed Biotechnology, Organic, Biopharma $1.2M–$1.8M
Tekla Capital Management
VC Fund
1 United States, Switzerland, France Series B, Series C, Series A Biotechnology, Health Care, Therapeutics $10M–$156M
Sandbox Industries
VC Fund
1 United States, India, France Series A, Seed, Series B Health Care, Biotechnology, Software $210k–$21M
Bank of Ireland Seed and Early Stage Equity fund
VC Fund
1 Ireland Seed, Series A Software, Photography, SaaS $384k–$1M
Mayo Clinic Ventures
VC Fund
1 United States, Israel, Ireland Seed, Series A, Series B Health Care, Biotechnology, Therapeutics $1.4M–$69M
Xenium Capital
VC Fund
1 Ireland Seed Medical Device, Health Care, Biotechnology $2.5M–$3.9M
Blue Wire Capital
VC Fund
1 United Kingdom, United States, France Seed, Pre-Seed, Series A Software, SaaS, FinTech $550k–$36M
ETV Capital SA
VC Fund
1 Ireland, United States, United Kingdom TV, Auctions, Computer
dlab
VC Fund
1 United States, Canada, France Seed, Pre-Seed, Convertible Note Blockchain, Software, Cryptocurrency $300k–$15M
Fulcrum Global Capital
VC Fund
1 United States, Canada, India Series A, Series B Biotechnology, Agriculture, Farming $3.8M–$20M
EQT Life Sciences
VC Fund
1 United States, The Netherlands, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $7.3M–$165M
EarlyBirdCapital
VC Fund
1 Ireland Seed Medical, Health Care, Biotechnology
HBM-MedFocus
VC Fund
1 United States, Ireland Series A, Series B, Series C Medical Device, Health Care, Therapeutics $5M–$26M
NCB Ventures
VC Fund
1 Japan, Ireland, United States Series A Apps, Sports, Internet
Moffett Investment Holdings
VC Fund
1 Ireland Series A, Series B Medical, Health Care, Biotechnology
Woodford Investment Management
VC Fund
1 United Kingdom, United States, Ireland Series B, Series A Biotechnology, Health Care, Medical
Access all 238 VC funds in Ireland Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 35 investments in Ireland Biotechnology startups

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 664
  • Round size: Seed $494k–$3.3M; Series A $2.2M–$12M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — raised $1.1M in 2021

Portfolio highlights

  • Oncomark — OncoMark is a UCD spin-out that develops companion diagnostic tests to support cancer drug development. Companion diagnostics allow pharmaceutical companies to select patients for which a drug may be particularly effective (patient stratification).The test can also be used during clinical trials to help reduce the numbers of patients required tocomplete a clinical trial and its duration, while also increasing the likelihood that the trial will be successful. The end result is improved outcome for cancer patients.The company has a portfolio of diagnostic tests in development, covering some of the key cancer types (breast, colorectal, prostate, melanoma), supported by €3.9m in EU R&D funding. There are currently 12 employees funded through 6 grants.The company was founded by Prof. William Gallagher in UCD and is led by Dr. Mairin Rafferty, the CEO/COO. The company has a strong advisory board, which includes Prof. John Crown and Prof. Bryan Hennessy.
  • Foodcloud — We connect businesses that have surplus food with Charities and Community Groups that need it.
  • Finovation Limited — Finovation Limited
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 19 investments in Ireland Biotechnology startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Western Development Commission
VC Fund · Ballaghaderreen, Roscommon, Ireland · 14 investments in Ireland Biotechnology startups

Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $702k–$3.9M; Venture - Series Unknown $753k–$17M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
  • Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Show all investments...

Kernel Capital
VC Fund · Cork, Cork, Ireland · 8 investments in Ireland Biotechnology startups

Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United Kingdom, France

Investor stats

  • Total investments: 94
  • Round size: Seed $531k–$4.4M; Series A $1.4M–$9M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — raised $34M in 2013

Portfolio highlights

  • Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
  • preico — Preico Network empowers Web2 and Web3 developers to create, own, and monetize crypto-native AI models on a decentralized platform
  • Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Show all investments...

Irrus Investments
VC Fund · Limerick, Limerick, Ireland · 8 investments in Ireland Biotechnology startups

Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland, Sweden, United States

Investor stats

  • Total investments: 34
  • Round size: Seed $713k–$4.7M; Venture - Series Unknown $1.2M–$24M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
  • Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
  • Adama Innovations — Sharp Conductive Single Crystal Diamond AFM Probes
Show all investments...

Atlantic Bridge
VC Fund · Dublin, Dublin, Ireland · 7 investments in Ireland Biotechnology startups

Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: United States, Ireland, United Kingdom

Investor stats

  • Total investments: 147
  • Round size: Series A $4.5M–$26M; Series B $10M–$62M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $88M in 2021

Portfolio highlights

  • Aiqudo — Aiqudo offers an artificial intelligence-based technology that connects voice computing to the mobile app ecosystem. Its Voice-to-Action platform lets people use natural voice commands to instantly execute actions in their mobile apps. The company was founded in 2017 and is headquartered in Campbell, California.
  • Output Sports — Discover Output's portable and affordable athlete testing and tracking device. Measure strength, power and speed in minutes giving accurate and reliable data.
  • Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Show all investments...

Fountain Healthcare Partners
VC Fund · Dublin, Dublin, Ireland · 6 investments in Ireland Biotechnology startups

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Ireland, United States, France

Investor stats

  • Total investments: 50
  • Round size: Series A $6.3M–$43M; Series B $5.5M–$68M; Series C $3.3M–$110M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $128M in 2019

Portfolio highlights

  • Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
  • Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
  • Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
Show all investments...

Seroba Life Sciences
VC Fund · Dublin, Dublin, Ireland · 6 investments in Ireland Biotechnology startups

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 48
  • Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $111M in 2017

Portfolio highlights

  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Show all investments...

Faber
VC Fund · Lisbon, Lisboa, Portugal · 5 investments in Ireland Biotechnology startups, 6 in the past 12 months

Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Portugal, United States, United Kingdom

Investor stats

  • Total investments: 97
  • Round size: Seed $549k–$5.2M; Pre-Seed $29k–$3M; Series A $2.5M–$25M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Porelio — Porelio is an environmental technology that provides purification technologies for water and industrial chemicals.
  • ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
  • InSpacePropulsion Technologies — Cost-effective, robust, and quickly available propulsion solutions, based on 10+ years of R&D and 40 years of combined experience in space propulsion.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 5 investments in Ireland Biotechnology startups

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: France, Germany, The Netherlands

Investor stats

  • Total investments: 520
  • Round size: Post-IPO Debt $18M–$726M; Debt Financing $16M–$352M
  • Lead/follow: 83% lead, 17% follow

Portfolio highlights

  • Ukrposhta — Ukrposhta sends and receives shipments from all over the world, as well as orders mail products sent to the most distant corners.
  • IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Elkstone Capital Partners
VC Fund · Dublin, Dublin, Ireland · 5 investments in Ireland Biotechnology startups

Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 94
  • Round size: Seed $797k–$5M; Series A $5.1M–$18M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $110M in 2023

Portfolio highlights

  • WrxFlo — WrxFlo deliver real time data insights and software solutions to allow business achieve greater levels of supply chain efficiencies
  • Danalto — Simple, cost-effective, high-accuracy Location Services for large open environments, both indoor and outdoor. Asset Tracking made simple!
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Show all investments...

AIB Seed Capital Fund
VC Fund · Dublin, Dublin, Ireland · 5 investments in Ireland Biotechnology startups

The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Ireland, United States, Jersey

Investor stats

  • Total investments: 49
  • Round size: Seed $549k–$3.3M; Series A $1.1M–$8.1M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
  • Offr — Offr is the new way to buy and sell property, quickly and transparently.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

Boole Investment Syndicate
VC Fund · Cork, Cork, Ireland · 4 investments in Ireland Biotechnology startups

Boole Investment Syndicate invests in new technology start-up's with scalability.

Show more...

Investment focus

  • Industry: Biotechnology, SaaS, Software
  • Stage:Seed, Series A
  • Geography: Ireland, Estonia, United States

Investor stats

  • Total investments: 10
  • Round size: Seed $623k–$2.2M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
  • eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
  • ArrayPatch — Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
Show all investments...

HBAN
VC Fund · Dublin, Dublin, Ireland · 4 investments in Ireland Biotechnology startups

HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical Device
  • Stage:Seed, Series A
  • Geography: Ireland, United Kingdom, United States

Investor stats

  • Total investments: 70
  • Round size: Seed $623k–$3.5M; Series A $1.2M–$9.2M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2018

Portfolio highlights

  • Movetru — Movetru a wearable device that aims to reduce injury and enhance rehabilitation.
  • FoodMarble — Your personal breath tester to identify food intolerances and reduce digestive symptoms. Ideal for managing IBS and SIBO, all from the comfort of home.
  • Glitch Ads — Launch AI Powered Google Ad Campaigns in Minutes. Think of us like an agency in a box. Built for speed. Priced for scaling companies. Powered by AI.
Show all investments...

HBAN Medtech Syndicate
VC Fund · 4 investments in Ireland Biotechnology startups

HBAN Medtech Syndicate

Show more...

Investment focus

  • Industry: Medical Device, Medical, Health Care
  • Stage:Seed, Series B
  • Geography: Ireland

Investor stats

  • Total investments: 13
  • Round size: Seed $1.3M–$11M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
  • SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Show all investments...

Atlantic Bridge University Fund
VC Fund · Dublin, Dublin, Ireland · 4 investments in Ireland Biotechnology startups

We invest in entrepreneurs with the ambition to create world-class companies of scale.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Big Data
  • Stage:Seed, Series A, Series B
  • Geography: Ireland, United States

Investor stats

  • Total investments: 33
  • Round size: Seed $823k–$3.9M; Series A $3.1M–$34M; Series B $16M–$80M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • PlasmaBound — PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, byenabling reliable adhesive joining which is stronger than the composite structures themselves.
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Show all investments...

SciFounders
VC Fund · San Francisco, California, United States · 3 investments in Ireland Biotechnology startups

We invest in highly technical startups from idea-stage up to Series A.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Ireland, United Kingdom

Investor stats

  • Total investments: 14
  • Round size: Seed $3.2M–$5M; Pre-Seed $400k–$400k; Series A $2.5M–$21M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
  • Current Surgical — Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
  • Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Show all investments...

Furthr VC
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotechnology startups

We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.

Show more...

Investment focus

  • Industry: Software, Medical Device, Medical
  • Stage:Seed, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 29
  • Round size: Seed $878k–$6.3M; Venture - Series Unknown $753k–$17M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: May invest from a new fund soon — raised $35M in 2019

Portfolio highlights

  • WrxFlo — WrxFlo deliver real time data insights and software solutions to allow business achieve greater levels of supply chain efficiencies
  • Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
  • Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
Show all investments...

Act Venture Capital
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotechnology startups

Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 160
  • Round size: Seed $823k–$5M; Series A $2.3M–$13M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: Likely still investing — raised $164M in 2022

Portfolio highlights

  • SiriusXT — SiriusXT is transforming cell and tissue imaging with the SXT-100, the first commercial, laboratory scale soft x-ray microscope.
  • Fresco — Fresco powers connected cooking experiences for appliance brands, enabling faster launches, lower R&D costs, and continuous innovation.
  • Engage-EHS — EcoOnline's easy-to-use software system is helping companies to transform their approach to health & safety, chemical safety & learning data reporting.
Show all investments...

The Yield Lab Europe
VC Fund · Dublin, Dublin, Ireland · 3 investments in Ireland Biotechnology startups

The Yield Lab Europe is a €55m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Ireland, France, United Kingdom

Investor stats

  • Total investments: 39
  • Round size: Seed $1M–$2.9M; Series A $2.1M–$10M; Venture - Series Unknown $1.7M–$9.6M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $52M in 2021

Portfolio highlights

  • BBLeap — Farming On Plant Level - We are BBLeap and we are going to create a LEAP in Agriculture! Enabling you to spray exactly what you want. No more, no less!
  • BiOceanOr — BiOceanOr harnessed the power of Marine Biology and AI to deliver bio-guided services that optimize fish welfare and fish growth, while supporting aquaculture sustainability standards
  • Marama Labs — Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lightstone Ventures
VC Fund · Menlo Park, California, United States · 2 investments in Ireland Biotechnology startups

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland, India

Investor stats

  • Total investments: 85
  • Round size: Series A $7M–$95M; Series B $18M–$100M; Series C $20M–$105M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • Psivant Therapeutics — PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
  • Crystalys Therapeutics — Transforming care for people living with gout.
Show all investments...

Enterprise Equity
VC Fund · Dundalk, Louth, Ireland · 2 investments in Ireland Biotechnology startups

Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 51
  • Round size: Seed $549k–$2.2M; Series B $2.6M–$7.5M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
  • SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
  • Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Show all investments...

Pareto Holdings
VC Fund · Miami, Florida, United States · 2 investments in Ireland Biotechnology startups, 13 in the past 12 months

Building world-changing companies in sunny Miami

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, France, United Kingdom

Investor stats

  • Total investments: 516
  • Round size: Seed $880k–$7.3M; Pre-Seed $125k–$3.5M; Series A $5.5M–$35M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Brekfuz — Brekfuz is an AI startup that builds an intelligent coordination platform called The Human API. The system transforms undocumented human knowledge and digital exhaust into structured endpoints to eliminate information bottlenecks. This allows both human teammates and autonomous AI agents to query institutional memory directly without waiting forhuman availability
  • Omen AI — Harness the power of Ai and proprietary sensing to prevent equipment failures.
  • PAVE Space — PAVE Space develops in-space transportation and satellite servicing technologies that enable movement and management of payloads across different orbits. The company builds spacecraft systems centered around a kickstage platform that transfers multi-ton payloads from low Earth orbit to target orbits within short timeframes using onboard propulsionsystems. Its core offering focuses on orbital mobility, providing services that bridge the gap between launch vehicles and final satellite deployment by repositioning payloads after initial launch. The platform is designed to integrate with multiple launch providers and supports both rideshare and dedicated missions through compatible interfaces and propulsion technologies.Beyond transportation, PAVE Space develops capabilities for in-orbit operations, including satellite inspection, life extension, docking, and servicing. These functions use a combination of propulsion systems, guidance and control algorithms, and autonomous technologies to manage spacecraft activities and extend satellite usability.
Show all investments...

Artis Ventures
VC Fund · San Francisco, California, United States · 2 investments in Ireland Biotechnology startups

Artis Ventures has spent over a decade backing bold teams who take the hard path, building market-defining companies to re-shape, re-invent, and re-make industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, India

Investor stats

  • Total investments: 145
  • Round size: Seed $2M–$47M; Series A $5M–$57M; Series B $20M–$127M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Ozlo Sleep — Ozlo Sleep is a science-driven sleep and audio technology company that supports and simplifies sleep rituals for clinical benefits, without the use of medication.
  • Arkenstone Defense — Arkenstone Defense provides an operating infrastructure platform that integrates government contracting and regulatory compliance into a centralized system for commercial technology companies. The platform manages complex defense requirements, including cleared workforce payroll, personnel security, audit readiness, and technical accreditationframeworks like CMMC and FedRAMP. By embedding these back-office operational controls directly into client environments, the company eliminates the administrative barriers that prevent commercial innovators from selling to the federal market.
  • Stateless Networks — Performance, Visibility. Simplicity...It's time for a beautiful network. Stateless is transforming network operations for software-centric networking. Tying together deep network understanding with state-of-the-art distributed systems, cloud, data science and gaming expertise, Stateless transforms network visibility, performance andresponse and helps accelerate the transition to modern network platforms, tying together physical and virtual layers. Focused on the enterprise data center, Stateless currently partners with the world’s leading network and infrastructure vendors (including VMware (VMW), Cisco Systems (CSCO), Cumulus Networks and others) to deliver solutions to some of the world’s largest private data center operators. We’re looking for software and networking engineers in Greater Seattle and the Bay Area with expertise in one or more of the following areas: Distributed Systems, Service Oriented Architecture, Complex Event processing, Functional Programming, Virtualization, Network design and deployment, Network programming, Network troubleshooting, configuration and performance tuning and SDN. Bonus points for experience working with cloud infrastructure (AWS, Azure, OpenStack) or low-level systems software (linux kernel, hypervisors, compilers/language runtimes), complex gaming systems or graphics and computational geometry. For more information visit http://www.statelessnetworks.com/ or follow Stateless on Twitter: @statelessntwrks.see
Show all investments...

Infinity Capital
VC Fund · Menlo Park, California, United States · 2 investments in Ireland Biotechnology startups

Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.

Show more...

Investment focus

  • Industry: Semiconductor, E-Commerce, Electronics
  • Stage:Series B, Series D
  • Geography: United States, Ireland, Canada

Investor stats

  • Total investments: 33
  • Lead/follow: no public data

Portfolio highlights

  • AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
  • BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
  • Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
Show all investments...

SVG Ventures
VC Fund · Los Gatos, California, United States · 2 investments in Ireland Biotechnology startups

We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Farming
  • Stage:Pre-Seed, Seed
  • Geography: United States, Canada, Ireland

Investor stats

  • Total investments: 86
  • Lead/follow: no public data

Portfolio highlights

  • FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
  • Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
  • Iamus Technologies — Iamus Technologies Limited is an Artificial Intelligence & Robotics company based in Ireland that has developed poultry specific robotic technology that empowers poultry farmers to make better and safer production decisions. Over the last 2 years we have been working globally with poultry processors in identifying KPIs that our robots cancontinuously gather on the ground in poultry sheds and feedback instantly to both producer and the relevant personnel back at the processing plant. Results to date are impressive with automatic and accurate data recovery from the birds on every part of the floor and analysis with real-time intervention now possible. These factors are key in addressing the growing demands of modern, intensive broiler production with the Iamus robot & platform meeting these requirements.
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Ireland Biotechnology startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 133
  • Round size: Series A $5.7M–$85M; Series B $12M–$92M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $209M in 2019

Portfolio highlights

  • Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
  • CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
  • Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Show all investments...

Lynett Capital
VC Fund · San Francisco, California, United States · 2 investments in Ireland Biotechnology startups

Lynett Capital is an early stage investment firm dedicated to the empowering technology companies.

Show more...

Investment focus

  • Industry: FinTech, Software, SaaS
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Kenya, Nigeria

Investor stats

  • Total investments: 29
  • Round size: Seed $120k–$3M; Pre-Seed $500k–$2.7M; Series A $2.5M–$49M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Juxta — Juxta delivers infrastructure-free positioning for people, assets, and robots. Track indoors, outdoors, and GPS-denied environments with the Universal Positioning System, Software SDK, and Asset Tags.
  • Ribbon — Go live with an inheritance center that your members deserve
  • Luminate — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Show all investments...

Ascentifi
VC Fund · Galway, Galway, Ireland · 2 investments in Ireland Biotechnology startups

Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Ireland

Investor stats

  • Total investments: 9
  • Round size: Seed $2.3M–$11M; Series A $9.2M–$34M; Venture - Series Unknown $3M–$3.5M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
  • Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
  • X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Show all investments...

ARCH Venture Partners
VC Fund · Chicago, Illinois, United States · 2 investments in Ireland Biotechnology startups

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 432
  • Round size: Series A $10M–$216M; Series B $14M–$250M; Series C $15M–$167M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Synchron — The endovascular brain computer interface.
  • Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
  • LifeMine Therapeutics — LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Gaingels
VC Fund · New York, New York, United States · 2 investments in Ireland Biotechnology startups

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 1258
  • Round size: Seed $1M–$8.5M; Series A $5.5M–$37M; Series B $16M–$100M
  • Lead/follow: 1% lead, 99% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Quadient Accounts Receivable by YayPay — YayPay accounts receivable automation software helps businesses collect faster, forecast cash flow accurately, and improve payment process. Automate your AR
  • Sharper Sense — Neuromodulation for Clear Senses
  • Willow Wealth — Willow Wealth is an alternative investment platform focused on generating income streams for investors. Get exclusive access to private market investments.
Show all investments...

DeepIE Ventures Management Co.
VC Fund · 2 investments in Ireland Biotechnology startups

DeepIE Ventures Management Co. operates as a venture capital firm.

Show more...

Investment focus

  • Industry: Manufacturing, AgTech, Software
  • Stage:Seed, Series A
  • Geography: Ireland, France, Switzerland

Investor stats

  • Total investments: 11
  • Round size: Seed $648k–$5.5M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • eID easy — One integration - access a worldwide network of QTSPs & CAs, for eSignatures, eID authentication & eSealing. Ensure full compliance with regulations.
  • ArrayPatch — Revolutionising drug delivery with painless microneedle patch technology. Backed by prestigious funding and award-winning innovation.
  • Marama Labs — Marama Labs is a developer of a novel UV-Vis spectroscopy technology for scientific-analytical instrumentation. It assists customers in identifying and measuring turbid samples' characteristics by using light's spectral properties. It offers an ultra-violet and visible spectrophotometer for measuring absorption, extinction, and scatteringspectra of clear and turbid liquids to help customers keep their samples intact, reduce sample preparation steps, and improve measurement turnaround time.
Show all investments...

LSP Dementia Fund
VC Fund · 2 investments in Ireland Biotechnology startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Series A, Series B, Post-IPO Equity
  • Geography: Belgium, Ireland, United States

Investor stats

  • Total investments: 5
  • Round size: Series A $39M–$39M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Aerska — Aerska develops targeted RNA medicines to treat brain diseases. By silencing genes that cause harm, we can preserve the minds and memories of those we love.
  • QurAlis — QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for amyotrophic lateral sclerosis (ALS). The company focuses on the link between genetics and disease in ALS and other neurological diseases, enabling doctors to successfully treat ALS .
  • New Amsterdam Pharma — We're advancing a new era of treatment for cardiovascular disease and other lipid-related conditions.
Show all investments...

Ascent Capital
VC Fund · Bangalore, Karnataka, India · 1 investments in Ireland Biotechnology startups

Ascent Capital is a leading India-focused independent private equity firm. They are one of the most experienced teams on ground with over 150+ years of collective experience in Indian capital markets. Over the past 15 years they have helped over 55 entrepreneurial teams build leading businesses across diverse sectors such as Technology, Ecommerce,Healthcare, Financial Services, Consumer Brands, Infrastructure, etc.

Show more...

Investment focus

  • Industry: Financial Services, Banking, Health Care
  • Stage:Series C, Series B
  • Geography: India, United States, Ireland

Investor stats

  • Total investments: 41
  • Round size: Series B $12M–$33M; Series C $2.5M–$50M
  • Lead/follow: 49% lead, 51% follow

Portfolio highlights

  • EnKash — Enkash is now Asia's 1st and Smartest Spend Management Platform that offer services like Account Payable, Accounts Receivable, Expense Management & many more.
  • Freshtohome — Freshtohome is an online grocery store that sells a range of seafood and meat to its users.The website’s range of products include fish, poultry, mutton, steaks, and fillet. Fish consists of shell, freshwater, and marine. Furthermore, it enables suppliers to supply their seafood and meat to the website.Freshtohome was launched in 2015 by ShanKadavil and is based in Bangalore.
  • Orbital — Orbital is a startup that is creating artificial intelligence data centers for deployment in low-Earth orbit to circumvent terrestrial power and cooling limits. The company specializes in satellite-based compute for AI inference workloads, utilizing continuous solar power and space's inherent radiative cooling.
Show all investments...

Cedas Foundation
VC Fund · Douglas, NA - Isle of Man, Isle of Man · 1 investments in Ireland Biotechnology startups

Cedas Foundation

Show more...

Investment focus

  • Industry: Biotechnology, Organic, Biopharma
  • Stage:Seed
  • Geography: Ireland, United States

Investor stats

  • Total investments: 2
  • Round size: Seed $1.2M–$1.8M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Hexafly — Hexafly is a biotechnology company that develops materials and sources form insects for aquafeed, chitin, and plant nutrition industry. It offers products from the sustainable farming of insects such as insect oil, protein, frass, and chitin. The company was founded in 2016 and headquartered in Kells, Meath, Ireland.
  • BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
Show all investments...

Tekla Capital Management
VC Fund · Boston, Massachusetts, United States · 1 investments in Ireland Biotechnology startups

We are dedicated to helping investors reach their investment goals. Get in touch with our team to explore Aberdeen's investment options.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series C, Series A
  • Geography: United States, Switzerland, France

Investor stats

  • Total investments: 51
  • Round size: Series A $10M–$65M; Series B $20M–$156M; Series C $28M–$133M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Oculis — Experience the Future of Eye Care: Oculis, a Clinical Biopharmaceutical Innovator, Pioneering Breakthrough Treatments for Ophthalmic Diseases & Transforming Lives Globally.
  • Amolyt Pharma — AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
  • Endeavor BioMedicines — Endeavor BioMedicines is a clinical-stage biotechnology company developing transformational medicines for life-threatening diseases.
Show all investments...

Sandbox Industries
VC Fund · Chicago, Illinois, United States · 1 investments in Ireland Biotechnology startups

We invest in innovation to drive lasting change in human livelinhood. We foster innovation to drive lasting change in industries that are crucial to our industry: healthcare, insurance and sustainability.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Seed, Series B
  • Geography: United States, India, France

Investor stats

  • Total investments: 100
  • Round size: Seed $210k–$3.2M; Series A $1.7M–$16M; Series B $5.5M–$21M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Anzen — Anzen is a management insurance and operations tool using real-time HRIS and SaaS integrations to identify and avoid management risks. The company was founded in 2020 and is headquartered in San Francisco, California, United States.
  • Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
  • Noctrix Health — Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Show all investments...

Bank of Ireland Seed and Early Stage Equity fund
VC Fund · Dublin, Dublin, Ireland · 1 investments in Ireland Biotechnology startups

The Bank of Ireland Seed and Early Stage Equity fund is a joint fund built with contributions from the Bank of Ireland, the University of Limerick Foundation, and government-backed The seed fund will invest in export-oriented high potential firms that operate in the technology, food and financial services sectors, inaddition to supporting patent and patent pending projects within Irish universities, targeting investments between EUR 100K-500K. The new fund comprises of a €17 million investment by Bank of Ireland, along with funding of €8 million from Enterprise Ireland and € 1million by the University of Limerick Foundation. It will be managed by

Show more...

Investment focus

  • Industry: Software, Photography, SaaS
  • Stage:Seed, Series A
  • Geography: Ireland

Investor stats

  • Total investments: 9
  • Round size: Seed $384k–$1M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2011

Portfolio highlights

  • Pulsate — Pulsate enables direct communication with customers based on their location, context, interests and behaviours. Pulsate allows you to design and push rich media content directly to customers devices. Deepen the relationship by establishing a customer dialogue. Allow users to reply to your campaigns, provide feedback and keep complaints outside ofsocial media. Maximize foot traffic by targeting street level or competitor locations. Combine with segmentation for optimal results. iBeacons:tm: enable you to understand indoor customer location and context with incredible accuracy. Easily manage deployment and configuration of iBeacons:tm: with the Pulsate cloud platform. Gain a deeper understanding of your mobile customers and a comprehensive view of each mobile campaign.
  • LegitFit — LegitFit is the operating system empowering gym/studio owners to succeed by automating their workflows, reducing cancellations and maximising their customers’ experience. We believe that those who help people achieve their health goals deserve to be empowered to manage less and earn more.
  • Certification Europe — Achieve and maintain compliance with the most in-demand standards with Amtivo. We help organisations reach their true potential.
Show all investments...

Mayo Clinic Ventures
VC Fund · Rochester, Minnesota, United States · 1 investments in Ireland Biotechnology startups

Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, Ireland

Investor stats

  • Total investments: 46
  • Round size: Seed $1.4M–$5.9M; Series A $5M–$26M; Series B $6.5M–$69M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $2M in 2010

Portfolio highlights

  • Anumana — Anumana is a new AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention
  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • Myosin Therapeutics — Advancing first-in-class therapies by targeting molecular motors (NMII) in oncology and neuroscience. Learn about our clinical trials for GBM, PDAC, and SUD.
Show all investments...

Xenium Capital
VC Fund · 1 investments in Ireland Biotechnology startups

Xenium Capital

Show more...

Investment focus

  • Industry: Medical Device, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Ireland

Investor stats

  • Total investments: 4
  • Round size: Seed $2.5M–$3.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Atrian Medical — AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
  • Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Blue Wire Capital
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotechnology startups

Investing globally in Frontier & Consumer businesses at pre-seed or seed.

Show more...

Investment focus

  • Industry: Software, SaaS, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 48
  • Round size: Seed $849k–$6M; Pre-Seed $550k–$3.5M; Series A $7M–$36M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Ovo Labs — Ovo Labs is developing therapeutics that boost egg quality to enhance IVF success, technology aims to extend the timeline when the chances of conception are high.
  • Ignota Labs — Ignota Labs for in silico toxicity prediction.
  • Caribou — We set Transfer Pricing policies and intragroup agreements for international businesses
Show all investments...

ETV Capital SA
VC Fund · London, England, United Kingdom · 1 investments in Ireland Biotechnology startups

ETV is one of Europe's leading providers of debt financing solutions for venture capital backed technology and healthcare businesses. Founded in 1999, ETV has a long and successful track record of investing in technology or intellectual property based companies across Europe and Israel, diversified by industry and development stage. Theyseek to set their selves apart from other venture lenders by being supportive, flexible and responsive to the needs of their customers, and a testament to their approach is the number of serial entrepreneurs, business angels and senior management that have come back to ETV both through the lifecycle of a company’s growth and for their subsequent ventures.

Show more...

Investment focus

  • Industry: TV, Auctions, Computer
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • 123.TV — German television channel, 123TV organizes cross-media auctions (TV and internet) on consumer products, for a public of all generations. The auction is reversed in the sense that the price fixed in advance to steady decreases over time until the amounts passed.
  • Nallatech — BittWare provides enterprise-class FPGA hardware and integrated systems featuring technology from AMD, Altera, and Achronix. Accelerate your network, storage, and compute solutions with low-risk, production-ready acceleration cards.
  • Stokes Bio — Stokes Bio develops and distributes microfluidic technology to its clients. It was founded in 2005 and is based in Ireland. It was acquired by Life Technologies in 2010.
Show all investments...

dlab
VC Fund · New York, New York, United States · 1 investments in Ireland Biotechnology startups

Early-stage venture capital and resources for startups exploring new frontiers in web3, decentralization, and blockchain technology.

Show more...

Investment focus

  • Industry: Blockchain, Software, Cryptocurrency
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 33
  • Round size: Seed $1.3M–$15M; Pre-Seed $300k–$650k
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Credit Coop — Earn through curated credit vaults backed by vetted borrowers, transparent on-chain repayments and programmable collateral. Lend to real businesses with Credit Coop.
  • Daler Trading — Pioneers in crypto liquidity and digital assets market making, specializing in crypto options and futures trading.
  • WeatherXM — Join WeatherXM's global network powered by blockchain. Earn WXM tokens with accurate, hyperlocal forecasts for agriculture, energy, and more.
Show all investments...

Fulcrum Global Capital
VC Fund · Mound City, Kansas, United States · 1 investments in Ireland Biotechnology startups

Feeding the world one investment at a time

Show more...

Investment focus

  • Industry: Biotechnology, Agriculture, Farming
  • Stage:Series A, Series B
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 25
  • Round size: Series A $3.8M–$13M; Series B $5.8M–$20M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Sabanto — Sabanto brings autonomy to agriculture with retrofit kits that transform existing tractors into fully autonomous machines. Boost efficiency, reduce labor, and farm 24/7 with the Sabanto Autonomy System. Book a demo today.
  • Plastomics — Plastomics is a biotechnology startup that focuses in developing the next generation of crops by using chloroplast genetic engineering. Its technology platform is applicable to different crops and traits. Plastomics provides solutions for the many current industry challenges.The company was founded in 2016 and headquartered in St. Louis,Missouri.
  • TastyUrban — TastyUrban is in the process of developing a new generation of restaurant usage and strategy.
Show all investments...

EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 1 investments in Ireland Biotechnology startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, The Netherlands, Switzerland

Investor stats

  • Total investments: 184
  • Round size: Series A $7.3M–$78M; Series B $12M–$110M; Series C $12M–$165M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $266M in 2023

Portfolio highlights

  • ActoGeniX — ActoGeniX is a biopharmaceutical company focused on the development and commercialization of a range of biological drugs. ActoGeniX was founded by Bernard Coulie and Mark Vaeck in 2006 and is based in Zwijnaarde, Belgium.
  • Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
  • Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
Show all investments...

EarlyBirdCapital
VC Fund · New York, New York, United States · 1 investments in Ireland Biotechnology startups

EarlyBirdCapital, Inc. (“EBC”) is a registered broker-dealer1 and member of the Financial Industry Regulatory Authority, Nasdaq Stock Market, Inc., Municipal Securities Rule Making Board, and Securities Insurance Protection Corporation2. EBC is a boutique investment bank that has developed an expertise in working with smaller capitalizationcompanies, special situation investments and Special Purpose Acquisition Companies (SPACs:tm:), a new concept they pioneered and developed that involves publicly-traded, industry-specific acquisition funds.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Ireland

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
Show all investments...

HBM-MedFocus
VC Fund · Irvine, California, United States · 1 investments in Ireland Biotechnology startups

MedFocus is a Private Equity Firm Dedicated to the Discovery and Investment in Emerging Medical Device Technology.

Show more...

Investment focus

  • Industry: Medical Device, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland

Investor stats

  • Total investments: 5
  • Round size: Series A $5M–$26M; Series B $17M–$18M
  • Lead/follow: 60% lead, 40% follow

Portfolio highlights

  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Shape Memory Medical — Smart polymer. Smart embolization. Smart choice. Reshaping your view of clinical success through the science of smart polymer.
  • Viseon — Experience Viseon's Advanced Digital Visualization CRANIALSPINALExperience Viseon's
Show all investments...

NCB Ventures
VC Fund · Dublin, Dublin, Ireland · 1 investments in Ireland Biotechnology startups

NCB Ventures invests across all development stages and is a venture capital company based in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Apps, Sports, Internet
  • Stage:Series A
  • Geography: Japan, Ireland, United States

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • WOTA — Human history is the history of our relationship with water. Water gave rise to our civilizations. Water has nourished people's livelihoods. This means that humans need water supplies, such as rivers and lakes, to survive. At WOTA, we desire to remove every limitation we have in relation to water. By integrating small water systems into the“big water infrastructure” of the past, we can achieve a more creative and sustainable way of life. That is our belief. In cities and deserts, remote islands, and outer space. We imagine a future where water is freely available to all people. Our work will always continue.
  • Gridstore — Gridstore™ is the leader in HyperConverged All-Flash Infrastructure for the Microsoft Cloud-Inspired Data Center. Our customers gain a 10X performance improvement over traditional storage as we put all-flash as close to the workload as possible. They realize 4X lower TCO by consolidation of three layers of infrastructure into one scalable layerbuilt on X86 hardware and 10X less management effort due to less management points and less infrastructure to manage. Gridstore's HyperConverged Appliances include both compute and storage in a single system, and provide external storage and work with any Windows servers and the HyperConverged Appliance, all driven by Gridstore's patented software. Gridstore software architecture delivers native Windows integration, per-VM I/O control, and elastic and independent scaling of resources. Gridstore is headquartered in Mountain View, CA. and its products and services are available through a global network of value-added resellers.
  • Authentic Japan — Authentic Japan manufactures a transmitter known as Coco Heli to realize the early detection of the missing person.In the summer of 2016, “Koko Heli” was born supported by various companies, groups, and individuals. , Kokoheli is becoming the "new idea" of safety climbing. In the future, the company aims to expand the service area fromthe mountain to the sea and to become a "JAF" in outdoor activities.
Show all investments...

Moffett Investment Holdings
VC Fund · Monaghan, Monaghan, Ireland · 1 investments in Ireland Biotechnology startups

Moffett Investment Holdings is an investment firm

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Series B
  • Geography: Ireland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Show all investments...

Woodford Investment Management
VC Fund · Oxford, Oxfordshire, United Kingdom · 1 investments in Ireland Biotechnology startups

Woodford Investment Management is a privately owned investment firm manages equity mutual funds. At Woodford, they don’t want to be just another fund management company. They want to create something different and better for their investors and they feel strongly that existing and potential clients are entitled to understand what they are doingwith their money.As investors, they are active, engaged, long-term, disciplined, diligent and focused. That’s a lot of things to say about their selves but each word is important in helping you to understand how they manage money – they will explain in more detail as they move along.Their investment approach and process are focused on value discovery, not price discovery. They believe that financial markets are inherently inefficient and that, through disciplined and diligent analysis, they can identify investment opportunities where market prices do not reflect long-term fundamental value. By exploiting this pervasive market characteristic, they believe they can create real long-term value for their investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 63
  • Lead/follow: no public data

Portfolio highlights

  • Revolut — Join 40+ million customers globally using Revolut to send money to 160+ countries, hold up-to 36 currencies in app, spend in 150+ currencies, and manage their money.
  • Atom Bank — Explore our savings accounts, mortgages and business loans in our digital banking app. Compare our savings rates and join the future of secure digital banking. FSCS protected.
  • Evofem Biosciences — Lithera is developing products for aesthetic medicine to address both medical and lifestyle indications. Its lead product is an injectable treatment to achieve local, selective fat tissue reduction (pharmaceutical lipoplasty). Using FDA registered drugs proven safe and effective in other indications, its product targets and stimulates natural fatmetabolism and achieves non-ablative, non-surgical fat tissue reduction in specific locations.
Show all investments...

Biotechnology VC funding in Ireland at a glance

Stats across 230 deals from 238 investors.

238
investors
in Ireland Biotechnology startups
230
deals
in Ireland Biotechnology startups
$4.8M
median round
in Ireland Biotechnology startups
49%
lead investors
lead at least one round
19%
Seed
most common funding stage

Access all 238 VC funds in Ireland Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 238 VC funds investing in Ireland Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists